Continue reading “‘Significant increase’ in protection vs Omicron from mRNA boosters, study says”
Fourth COVID-19 shot needed, says German health minister
BERLIN, Dec 22 (Reuters) – German Health Minister Karl Lauterbach said on Wednesday that a fourth vaccination will be necessary in the fight against the coronavirus pandemic due to the more contagious Omicron variant. He said that Germany has ordered 80 million doses of a vaccine made by Biontech specifically targeting Omicron and should arrive in April or May. Germany has also ordered four million doses of the newly approved vaccine Novavax – seen as more acceptable to vaccine sceptics – and 11 million doses of the new Valneva shot, which is waiting for marketing authorisation, Lauterbach said. The Novavax shots will arrive in the country in January, Lauterbach told a news conference. “An offensive booster campaign is our most important building block in the fight against Omicron,” the health minister said. Lauterbach threw his support behind a general vaccine mandate, saying that without one, it would not be possible to manage coming waves of infection over the long term. According to Lothar Wieler, president of Germany’s Robert Koch Institute (RKI) for infectious diseases, Omicron will be responsible for most coronavirus infections in Germany within three weeks. “Christmas should not become the spark that starts the Omicron blaze,” RKI chief Lothar Wieler told the same news conference, adding people should limit contacts to an absolute minimum. (Reporting by Zuzanna Szymanska and Miranda Murray Editing by Madeline Chambers.
Omicron milder than Delta in UK – report…… Another study finds Omicron MAY NOT be milder than Delta: UK Study
he Omicron coronavirus variant seems to be causing milder COVID-19 symptoms compared to the Delta strain, according to conclusions set to be published by British government scientists. People living in the United Kingdom are less likely to become ill, Politico reported on Wednesday citing the study, noting high vaccination percentage as one of the main reasons driving high protection against COVID-19. Furthermore, the research is set to show that people who have been vaccinated with a booster dose have a significantly reduced chance of ending up in a hospital due to COVID-19. The report comes as the UK registers more than 90,000 new infections a day over the past week – the highest number since the start of the pandemic. Continue reading “Omicron milder than Delta in UK – report…… Another study finds Omicron MAY NOT be milder than Delta: UK Study”
Biden plan to spur 200 million-500mln COVID tests to market -Fauci
UK’s Johnson to say in 48 hours whether more COVID rules needed….. Europe weighs Omicron curbs as Biden turns to military medics
Europe weighs Omicron curbs as Biden turns to military medics
Home Test Kits In Stock For Immediate Shipment
For $15 and 15 Minutes You Can Have Your Life Back
Now You Can Have BBQ’s, Birthday Parties and Weddings and Not Have Them Turn into Super Spreader Events
Continue reading “Home Test Kits In Stock For Immediate Shipment”
NHL to pause season over COVID
The coronavirus pandemic still poses a threat, and will continue to do so, but the medical field and infectious disease experts have learned plenty about the virus and its spread. Tools such as safe vaccines and masking options offer individual protection. That means sports leagues will not shut down like they did 20 months ago. But with each passing day, it seems another sport or league is once again being affected by this pandemic, with postponements and infections. For example, 51 NFL players went on the COVID-19 reserve list Monday, including Kansas City Chiefs star Travis Kelce.
Wall St falls as Omicron’s spread stokes fears of tighter curbs
Traders work on the floor of the New York Stock Exchange (NYSE) in New York City, U.S., December 3, 2021. REUTERS/Brendan McDermid
Dec 20 (Reuters) – Wall Street’s main indexes opened lower on Monday, dragged by concerns about the impact of tighter COVID-19 curbs on the global economy, and a potentially devastating setback to President Joe Biden’s investment bill. The Dow Jones Industrial Average (.DJI) fell 143.32 points, or 0.41%, at the open to 35,222.12. The S&P 500 (.SPX) opened lower by 32.74 points, or 0.71%, at 4,587.90, while the Nasdaq Composite (.IXIC) dropped 236.68 points, or 1.56%, to 14,933.00 at the opening bell.
Most of the World’s Vaccines Likely Won’t Prevent Infection From Omicron
A growing body of preliminary research suggests the COVID vaccines used in most of the world offer almost no defense against becoming infected by the highly contagious omicron variant. All vaccines still seem to provide a significant degree of protection against serious illness from omicron, which is the most crucial goal. But only the Pfizer and Moderna shots, when reinforced by a booster, appear to have initial success at stopping infections, and these vaccines are unavailable in most of the world.
The other shots — including those from AstraZeneca, Johnson & Johnson and vaccines manufactured in China and Russia — do little to nothing to stop the spread of omicron, early research shows.
Continue reading “Most of the World’s Vaccines Likely Won’t Prevent Infection From Omicron”
Dow falls 550 pts premarket on virus worries
The Dow Jones Industrial Average index dropped over 550 points in premarket trade on Monday as concerns surrounding the Omicron coronavirus variant seemingly affected market sentiment. United States President Joe Biden is set to address the nation on December 21 and outline the details of the government’s Winter Plan to “fight against COVID-19.” Furthermore, Senator Joe Manchin confirmed yesterday that he will not support Biden’s spending package in its current form. The Dow Jones Industrial Average declined by 552 points or 1.57%, the Nasdaq 100 was 1.71% down and the S&P 500 decreased by 1.70% at 4:04 am ET.